The largest community of pharma leaders

GRAMINEX L.L.C. Appoints Alexander Grantz, Ph.D. as Chief Scientific Officer

SAGINAW, Mich.–()–Graminex® L.L.C., producer of Graminex® Non-Solvent Flower Pollen Extracts™, is pleased to appoint Alexander Grantz, Ph.D., to the position of Chief Scientific Officer. Grantz will focus on increasing Graminex brand recognition, by developing a more defined scientific understanding of Graminex® Flower Pollen Extract™ products.

“Graminex® is looking forward to Alex as an additional team member representing our products. With his extensive marketing and scientific background in health and nutrition, we look forward to increasing awareness of the health benefits our products offer,” said Colleen May. “With the experience Alex brings, we hope to better meet customer needs by providing an experienced, science based representative.”

“I’m looking forward to helping our current and future customers formulate and market great products that contain Graminex’s natural non-solvent flower pollen extracts,” said Alex Grantz. “I’ve been impressed with the passion for clinical research and product development that is core to Graminex’s approach to business.”

Grantz joins Graminex from an industry background in the health and nutritional ingredients. In the past he has worked with Wilbur-Ellis Company and its subsidiary, Connell, a distributor of specialty chemicals and nutritional ingredients in Asia. Grantz holds a doctorate degree in biochemistry from the University of California, Berkeley where he studied the structural biology of plant signal transduction pathways.

About Graminex®LLC

Graminex® L.L.C. is the leading producer of natural and solvent free Graminex® Flower Pollen Extract™. Graminex® directly owns and manages more than 6,500 acres of farmland in Northwest Ohio to meet its customer’s needs. Graminex’s active ingredients are grown and processed for dietary supplement, nutraceutical, pharmaceutical, food and skin care industries. Graminex® markets its own line of dietary supplements, focusing on prostate care, urinary care, menopausal support, and skin care.

For further information please contact Graminex® L.L.C., Colleen May at +1 (419) 278-1023 or by e-mail at info@graminex.com. You may also visit www.graminex.com.

Source

Recent Articles

Sperm Bank Market: COVID-19 Business Continuity Plan | Evolving Opportunities with Androcryos and Cryos International-Denmark ApS | Technavio

LONDON--(BUSINESS WIRE)-- #GlobalSpermBankMarket--The Global Sperm Bank Market will grow by $...

Global Hereditary Transthyretin Amyloidosis (hATTR) Competitive Landscape, Market Insights, Epidemiology and Forecast 2017-2020 & 2030 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Hereditary Transthyretin Amyloidosis (hATTR) - Competitive Landscape, Market Insights,...

Strive Health Welcomes David Thornton as Chief People Officer

DENVER--(BUSINESS WIRE)-- #executiveteam--Leading specialized kidney care company Strive Health today announced...

Accenture Puts Data Science to Work for Pediatric Leukemia Research

NEW YORK--(BUSINESS WIRE)--Accenture has built a data and analytics approach to...

FDA Grants RMAT Designation to MultiStem Cell Therapy for the Treatment of Acute Respiratory Distress Syndrome

CLEVELAND--(BUSINESS WIRE)---- $ATHX #ARDS--MultiStem is the only cell therapy program for...
2020 Call for Writers

Are you looking to inspire others in the pharma industry through your writing? You’re invited to submit your articles to become a Featured Writer for The Pharmaceutical Marketing Group website.